학술논문
A pragmatic, multicentre, double-blind, placebocontrolled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Document Type
Article
Author
Banerjee, Sube; Farina, Nicolas; Henderson, Catherine; High, Juliet; Stirling, Susan; Shepstone, Lee; Fountain, Julia; Ballard, Clive; Bentham, Peter; Burns, Alistair; Fox, Chris; Francis, Paul; Howard, Robert; Knapp, Martin; Leroi, Iracema; Livingston, Gill; Nilforooshan, Ramin; Nurock, Shirley; O'Brien, John; Price, Annabel
Source
Health Technology Assessment; 10/31/2023, Vol. 27 Issue 23/24, pvii-108, 116p
Subject
Language
ISSN
13665278